
A major objective of phase I trials is to determine the toxicity of a new zzso zzso However phase I trials should be conducted with therapeutic zzso After the starting dose has been zzso zzso should be reached safely and efficiently by dose escalation based on the animal zzso data and zzso of toxicity observed in patients under the study, and there is no established scheme for dose zzso zzso and zzso at increasing dose in the same patient may be useful for determining the cumulative toxicity and predicting zzso zzso A flow of clinical trials recently introduced by the zzso is cited as a new concept of screening of the zzso activity of new zzso drugs in phase II zzso zzso factors that may affect the zzso activity should be taken into consideration in phase II zzso In the conduct of phase III trials, there are many difficulties with historical controls, and comparative study should be performed in a controlled zzso fashion with zzso of patients who are zzso by known zzso zzso In phase IV trials, long-term follow-up of patients is required to demonstrate advantage in survival rates and to monitor zzso zzso The advantages and disadvantages of zzso and zzso clinical trials are also zzso 

